What does innovation mean to you?
To me, innovation means turning scientific knowledge into real-world impact. It’s about pushing boundaries, questioning the status quo, and finding smarter, more effective ways to solve problems. In healthcare, that means making complex data - like the gut microbiome - accessible, understandable, and genuinely useful for people in their everyday lives. Innovation isn’t just about technology;it’s about creating value and improving lives (through science).
What do you believe is the most important capability for companies to thrive in the economy of tomorrow?
The most important capability is adaptability powered by science and data. Companies that can stay agile, embrace innovation, and make evidence-based decisions will be best equipped to thrive in a fast-changing, health-conscious world.
How can we leverage our collective strength to create a more prosperous future?
By collaborating across disciplines—science, technology, and society—we can turn knowledge into impact. Sharing data, expertise, and diverse perspectives allows us to build smarter solutions, empower individuals, and drive meaningful change for a healthier, more prosperous future.
Describe your project and work and what makes it so innovative?
At myBioma, we’ve developed a cutting-edge platform that analyses the human gut microbiome using NG-sequencing and delivers personalized, science-backed insightsand recommendations. Our innovation lies in translating complex microbiome data into actionable health advice, empowering individuals to make informed lifestyle and nutritional choices. What makes it truly unique is the combination of clinical precision, user-centric design, and our commitment to scientific rigor and transparency.